Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Gilead Sciences
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Infection with genotype 2 or 3 HCV infection
Cirrhosis determination
Individual is treatment-experienced
Screening laboratory values within defined thresholds
Individual has not been treated with any investigational drug or device within 30 days of the Screening visit
Use of highly effective contraception methods if female of childbearing potential or sexually active male
You may not be if
Prior exposure to a direct-acting antiviral drug targeting the HCV NS5B polymerase
Pregnant or nursing female or male with pregnant female partner
Current or prior history of clinical hepatic decompensation
History of clinically-significant illness or any other major medical disorder that may interfere with treatment, assessment, or compliance with the study protocol
Excessive alcohol ingestion or significant drug abuse